Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report

Detalles Bibliográficos
Autores principales: He, Xi, Jiao, Xiao-Dong, Liu, Ke, Qin, Bao-Dong, Wu, Ying, Ling, Yan, Liu, Jun, Xu, A-Qiao, Song, Kun, Zang, Yuan-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140796/
https://www.ncbi.nlm.nih.gov/pubmed/34036227
http://dx.doi.org/10.1200/PO.20.00534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140796/
https://www.ncbi.nlm.nih.gov/pubmed/34036227
http://dx.doi.org/10.1200/PO.20.00534

Ejemplares similares